Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADVM |
---|---|---|
09:32 ET | 40482 | 7.42 |
09:41 ET | 193 | 7.5 |
09:43 ET | 300 | 7.53 |
09:45 ET | 100 | 7.465 |
09:52 ET | 101 | 7.4 |
10:01 ET | 5426 | 7.4999 |
10:08 ET | 100 | 7.5071 |
10:10 ET | 100 | 7.47 |
10:17 ET | 200 | 7.49 |
10:26 ET | 137 | 7.4303 |
10:32 ET | 100 | 7.485 |
10:42 ET | 1070 | 7.505 |
10:44 ET | 100 | 7.55 |
10:46 ET | 100 | 7.54 |
10:48 ET | 12006 | 7.6 |
10:50 ET | 300 | 7.59 |
10:51 ET | 300 | 7.63 |
11:00 ET | 100 | 7.61 |
11:04 ET | 200 | 7.6 |
11:06 ET | 1500 | 7.54 |
11:08 ET | 2967 | 7.5 |
11:09 ET | 850 | 7.47 |
11:13 ET | 100 | 7.455 |
11:15 ET | 100 | 7.44 |
11:20 ET | 600 | 7.465 |
11:22 ET | 137 | 7.4766 |
11:24 ET | 100 | 7.45 |
11:27 ET | 100 | 7.39 |
11:31 ET | 200 | 7.44 |
11:33 ET | 200 | 7.39 |
11:36 ET | 255 | 7.42 |
11:45 ET | 1000 | 7.4756 |
11:54 ET | 200 | 7.46 |
11:58 ET | 200 | 7.46 |
12:02 ET | 400 | 7.45 |
12:03 ET | 490 | 7.47 |
12:05 ET | 576 | 7.47 |
12:09 ET | 100 | 7.47 |
12:12 ET | 400 | 7.48 |
12:18 ET | 100 | 7.44 |
12:30 ET | 100 | 7.45 |
12:39 ET | 5628 | 7.49 |
12:41 ET | 200 | 7.47 |
12:45 ET | 100 | 7.44 |
12:48 ET | 200 | 7.46 |
12:56 ET | 850 | 7.4493 |
12:57 ET | 300 | 7.46 |
12:59 ET | 704 | 7.48 |
01:10 ET | 506 | 7.48 |
01:14 ET | 202 | 7.5 |
01:15 ET | 172 | 7.485 |
01:17 ET | 100 | 7.5 |
01:19 ET | 400 | 7.49 |
01:21 ET | 161 | 7.48 |
01:24 ET | 100 | 7.49 |
01:26 ET | 1633 | 7.43 |
01:32 ET | 100 | 7.44 |
01:39 ET | 100 | 7.42 |
01:46 ET | 100 | 7.47 |
01:50 ET | 400 | 7.44 |
01:51 ET | 100 | 7.4 |
01:55 ET | 100 | 7.42 |
02:02 ET | 100 | 7.425 |
02:04 ET | 400 | 7.4 |
02:06 ET | 200 | 7.4 |
02:08 ET | 100 | 7.42 |
02:15 ET | 100 | 7.39 |
02:20 ET | 600 | 7.42 |
02:26 ET | 200 | 7.4 |
02:27 ET | 100 | 7.425 |
02:36 ET | 100 | 7.38 |
02:38 ET | 904 | 7.4 |
02:42 ET | 100 | 7.43 |
02:44 ET | 100 | 7.43 |
02:45 ET | 200 | 7.41 |
02:49 ET | 100 | 7.45 |
02:54 ET | 100 | 7.44 |
02:56 ET | 200 | 7.44 |
03:00 ET | 100 | 7.45 |
03:02 ET | 100 | 7.47 |
03:05 ET | 200 | 7.46 |
03:07 ET | 300 | 7.44 |
03:09 ET | 700 | 7.425 |
03:14 ET | 573 | 7.39 |
03:16 ET | 1522 | 7.43 |
03:18 ET | 113 | 7.4432 |
03:20 ET | 200 | 7.47 |
03:30 ET | 940 | 7.51 |
03:32 ET | 100 | 7.51 |
03:36 ET | 200 | 7.51 |
03:39 ET | 971 | 7.52 |
03:41 ET | 394 | 7.5 |
03:43 ET | 600 | 7.49 |
03:50 ET | 700 | 7.44 |
03:52 ET | 4579 | 7.51 |
03:54 ET | 332 | 7.4871 |
03:56 ET | 1097 | 7.49 |
03:57 ET | 3812 | 7.44 |
03:59 ET | 100013 | 7.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adverum Biotechnologies Inc | 156.0M | -0.9x | --- |
Century Therapeutics Inc | 144.0M | -0.8x | --- |
Quantum-Si Inc | 150.9M | -1.5x | --- |
Actuate Therapeutics Inc | 156.5M | -5.0x | --- |
Achieve Life Sciences Inc | 156.6M | -4.2x | --- |
Acumen Pharmaceuticals Inc | 155.0M | -2.2x | --- |
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection. It also developing an early-stage pipeline of gene therapy programs.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $156.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.03 |
EPS | $-7.99 |
Book Value | $8.23 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.